Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 65

Related Articles by Review for PubMed (Select 12828829)

1.

Inadvertent sulfonylurea overdosage and hypoglycemia in an elderly woman: failure of serum hypoglycemia screening.

Earle KE, Rushakoff RJ, Goldfine ID.

Diabetes Technol Ther. 2003;5(3):449-51.

PMID:
12828829
2.

Octreotide for sulfonylurea-induced hypoglycemia following overdose.

Carr R, Zed PJ.

Ann Pharmacother. 2002 Nov;36(11):1727-32. Review.

PMID:
12398568
3.

Hypoglycemia following inadvertent and factitious sulfonylurea overdosages.

Klonoff DC, Barrett BJ, Nolte MS, Cohen RM, Wyderski R.

Diabetes Care. 1995 Apr;18(4):563-7. Review.

PMID:
7497872
4.

Sulphonylurea-induced hypoglycaemia in type 2 diabetes mellitus: a review.

Burge MR, Sood V, Sobhy TA, Rassam AG, Schade DS.

Diabetes Obes Metab. 1999 Jul;1(4):199-206. Review. No abstract available.

PMID:
11228754
5.

Long-acting sulfonylureas -- long-acting hypoglycaemia.

Veitch PC, Clifton-Bligh RJ.

Med J Aust. 2004 Jan 19;180(2):84-5. Review. No abstract available.

PMID:
14723592
6.

Insulin & C-peptide levels in sulfonylurea-induced hypoglycemia: a systematic review.

DeWitt CR, Heard K, Waksman JC.

J Med Toxicol. 2007 Sep;3(3):107-18. Review.

7.

Suicide attempt by an overdose of sitagliptin, an oral hypoglycemic agent: a case report and a review of the literature.

Furukawa S, Kumagi T, Miyake T, Ueda T, Niiya T, Nishino K, Murakami S, Murakami M, Matsuura B, Onji M.

Endocr J. 2012;59(4):329-33. Epub 2012 Jan 21. Review.

8.

[Hypoglycemia in diabetes mellitus].

Irsigler K.

Acta Med Austriaca. 1992;19(4):100-5. Review. German.

PMID:
1290316
9.

Emergency management of oral hypoglycemic drug toxicity.

Rowden AK, Fasano CJ.

Emerg Med Clin North Am. 2007 May;25(2):347-56; abstract viii. Review.

PMID:
17482024
10.

[Hypoglycemic risk of insulinotropic drugs].

Böhm R, Cascorbi I, Herdegen T.

Med Monatsschr Pharm. 2009 Dec;32(12):453-8. Review. German.

PMID:
20088347
11.

[Clinical efficacy of glimepiride].

Kaneko T, Sakamoto N.

Nihon Rinsho. 1997 Nov;55 Suppl:152-7. Review. Japanese. No abstract available.

PMID:
9434460
12.

[Measures to meet the side effects of sulfonylurea (SU) in the treatment of type 2 diabetes].

Furukawa H, Ishida H.

Nihon Rinsho. 2002 Sep;60 Suppl 9:357-61. Review. Japanese. No abstract available.

PMID:
12387018
13.

Sulfonylurea treatment of type 2 diabetes mellitus: focus on glimepiride.

Korytkowski MT.

Pharmacotherapy. 2004 May;24(5):606-20. Review.

PMID:
15162895
14.

Role of sulfonylureas in non-insulin-dependent diabetes mellitus: Part II--"The cons".

Heine RJ.

Horm Metab Res. 1996 Sep;28(9):522-6. Review.

PMID:
8911991
15.

An overview of the safety and tolerance of glimepiride.

Schneider J.

Horm Metab Res. 1996 Sep;28(9):413-8. Review.

PMID:
8911975
16.

The molar ratio of insulin to C-peptide. An aid to the diagnosis of hypoglycemia due to surreptitious (or inadvertent) insulin administration.

Lebowitz MR, Blumenthal SA.

Arch Intern Med. 1993 Mar 8;153(5):650-5. Review. Erratum in: Arch Intern Med 1993 Jun 14;153(11):1310.

PMID:
8439228
17.

Early insulin use in type 2 diabetes: what are the cons?

Chiasson JL.

Diabetes Care. 2009 Nov;32 Suppl 2:S270-4. doi: 10.2337/dc09-S321. Review. No abstract available.

18.

Insulin secretagogues: who, what, when, and how?

Dailey G.

Curr Diab Rep. 2005 Oct;5(5):329-32. Review.

PMID:
16188166
19.

Pioglitazone hydrochloride/glimepiride.

Blake EW.

Drugs Today (Barc). 2007 Jul;43(7):487-97. Review.

PMID:
17728849
20.

Sulfonylureas and hypoglycaemia.

Del Prato S, Aragona M, Coppelli A.

Diabetes Nutr Metab. 2002 Dec;15(6):444-50; discussion 450-1. Review. No abstract available.

PMID:
12678466
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk